Access to Medicines
Funding the Fight
Transparency & Accountability
Do something now
How Biden Could Use the DPA to Increase Vaccine Production
Dummy’s guide to how trade rules affect access to COVID-19 vaccines
What Will it Take to End the COVID-19 Pandemic?
At WTO, a battle for access to COVID-19 vaccines
‘Suspend patent to allow faster production’
Activists Demand Rich Countries Suspend Patent Laws and Share Vaccines Freely
Medicines Patent Pool expands deal for access to key HIV drug to several upper middle-income countries
Regulatory discoherence: The case of remdesivir
NIH fails to disclose enough details about drug licensing, watchdog report finds
Experts call for WTO rules waiver as concerns grow over critical COVID-19 supplies
Developing Nations Push for Covid Vaccines Without the Patents
Norway criticised for siding with drug companies in conflict over COVID19 patents
WTO Holds Off On Waiving IP For COVID-19 Vaccines
To Oppose Trump Politicizing of Covid-19, DC Rally to Demand “People’s Vaccine” Be Free and ...
Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandem...
The unequal scramble for coronavirus vaccines — by the numbers
Suspend patents on COVID-19 drugs in India to ensure accessibility & affordability
‘Step in the Right Direction,’ Say Healthcare Advocates as Biden Vows to Share Any Covid-19 Vaccin...
Health Authorities Aim to Build Alternative to COVID-19 Nationalism
How Secret Deals Could Keep a COVID-19 Drug Out of Reach for Millions